The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy

References

• Förster G, Otto E, Hansen C, Ochs K, Kahaly G. Analysis of orbital T cells in thyroid-associated ophthalmopathy. Clin Exp Immunol 1998; 112: 427–434
   PubMed Web of Science ®Google Scholar
• Grubeck-Loebenstein B, Trieb K, Sztankay A, Holter W, Anderl H, Wick G. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ an specifically recognize autologous fibroblasts. J Clin Invest 1994; 93: 2738–2743
   PubMed Web of Science ®Google Scholar
• Weetman AP, Ajjan RA, Watson PF. Cytokines and Graves' disease. Bailliére's Clin Endocrinol Met 1997; 11: 481–497
   Google Scholar
• Romagnani R. Regulatory T cells: Which role in the pathogenesis and treatment of allergic disorders?. Allergy 2006; 61: 3–14
   PubMed Web of Science ®Google Scholar
• Yang D, Hiromatsu Y, Hoshino T, Inoue Y, Itoh K, Nonaka K. Dominant infiltration of TH1-type CD4+ T cells at the retrobulbar space of patients with thyroid-associated ophthalmopathy. Thyroid 1999; 9: 305–310
   PubMed Web of Science ®Google Scholar
• Ward LS, Fernandes GA. Serum cytokine levels in autoimmune and non-autoimmune hyperthyroid states. Braz J Med Biol Res 2000; 33: 65–69
   Google Scholar
• Bahn RS. Pathophysiology of Graves' ophthalmopathy: The cycle of disease. J Clin Endocrinol Metab 2003; 88: 1939–1946
   PubMed Web of Science ®Google Scholar
• Braley-Mullen H, Sharp GC, Tang H, Chen K, Kyriakos M, Bickel JT. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis. Am J Pathol 1998; 152: 1347–1358
   PubMedGoogle Scholar
• Trinchieri G, Scott P. The role of interleukin 12 in the immune response, disease and therapy. Immunol Today 1994; 15: 460–463
   PubMedGoogle Scholar
• Sanderson CJ, Campbell HD, Young IG. Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol Rev 1988; 102: 29–50
   PubMed Web of Science ®Google Scholar
• Sanderson CJ. Interleukin-5, eosiniphils, and disease. Blood 1992; 79: 3101–3109
   PubMed Web of Science ®Google Scholar
• Bagley CJ, Lopez AF, Vadas MA. New frontiers for IL-5. J Allergy Clin Immunol 1997; 99: 725–728
   PubMedGoogle Scholar
• Balazs C, Kiss E, Leovey A, Farid NR. The immunosuppressive effect of methimazole on cell-mediated immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals. Clin Endocrinol (Oxf) 1986; 25: 7–16
   PubMedGoogle Scholar
• Werner SC. Modification of classification of eye changes of Graves' disease: Recommendations of the ad hoc Committee of American Thyroid Association. J Clin Endocrinol Metab 1977; 44: 203–204
   PubMed Web of Science ®Google Scholar
• Pinkse GGM, Tysma OHM, Bergen CAM, Kester MGD, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW, Roep BO. Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes. Proc Natl Acad Sci USA 2005; 102: 18425–18430
   PubMed Web of Science ®Google Scholar
• Hidaka Y, Okumura M, Shimaoka Y, Takeoka K, Tada H, Amino N. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis. Thyroid 1998; 8: 235–239
   PubMed Web of Science ®Google Scholar
• Heuer M, Aust G, Ode-Hakim S, Scherbaum WA. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 1996; 6: 97–106
   PubMed Web of Science ®Google Scholar
• Takeoka K, Hidaka Y, Hanada H, Nomura T, Tanaka S, Takano T, Amino N. Increase in serum levels of autoantibodies after attack of seasonal allergic rhinitis in patients with Graves' disease. Int Arch Allergy Immunol 2003; 132: 268–276
   Google Scholar
• Molnar I, Horvath S, Balazs C. Detectable serum IgE levels in Graves' ophthalmopathy. Eur J Med Res 1996; 1: 543–546
   Google Scholar
• Raikow RB, Dalbow MH, Kennerdell JS, Compher K, Machen L, Hiller W, Blendermann D. Immunohistochemical evidence for IgE involvement in Graves' orbitopathy. Ophthalmology 1990; 97: 629–635
   Google Scholar
• Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335: 99–107
   PubMed Web of Science ®Google Scholar
• Hidaka Y, Okumura M, Fukata S, Shimaoka Y, Takeoka K, Tada H, Kuma K, Amino N. Increased serum concentration of interleukin-12 in patients with silent thyroiditis and Graves' disease. Thyroid 1999; 9: 149–153
   Google Scholar
• Tamaru M, Matsuura B, Onji M. Increased levels of serum interleukin-12 in Graves' disease. Eur J Endocrinol 1999; 141: 111–116
   PubMed Web of Science ®Google Scholar
• Tamaru M, Matsuura B, Miyauchi S, Onji M. Dendritic cells produce interleukin-12 in hyperthyroid mice. Eur J Endocrinol 1999; 141: 625–629
   Google Scholar
• Kocjan T, Wraber B, Kocijančič A, Hojker S. Methimazole upregulates T-cell-derived cytokines without improving the existing Th1/Th2 imbalance in Graves' disease. J Endocrinol Invest 2004; 27: 302–307
   Google Scholar
• Roubenhoff R, Harris TB, Abad LW, Wilson PW, Dallal GE, Dinarello CA. Monocyte cytokine production in an elderly population: Effect of age and inflammation. J Gerontol A Biol Sci Med Sci 1998; 53: M20–M26
   Google Scholar
• Nikolich-Zugich J. T cell aging: Naive but not young. J Exp Med 2005; 201: 837–840
   PubMedGoogle Scholar
• Eaton SM, Burns EM, Kusser K, Randall TD, Haynes L. Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med 2004; 200: 1613–1622
   PubMed Web of Science ®Google Scholar